Detalhe da pesquisa
1.
Cognitive impairment in multiple sclerosis: diagnosis and monitoring.
Neurol Sci
; 42(12): 5183-5193, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33796947
2.
Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.
Front Neurol
; 14: 1060696, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36959824
3.
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Neurol Ther
; 12(6): 2177-2193, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37861931
4.
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.
Front Neurol
; 13: 897275, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35572939
5.
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Front Immunol
; 13: 842354, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35386690
6.
Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.
Brain Behav
; 11(4): e02044, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33486890
7.
Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study).
Mult Scler Relat Disord
; 50: 102860, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33647591
8.
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS.
Neurol Neuroimmunol Neuroinflamm
; 8(2)2021 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33408167
9.
CSF chitinase 3-like-1 association with disability of primary progressive MS.
Neurol Neuroimmunol Neuroinflamm
; 7(5)2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32611760
10.
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.
Clin Chim Acta
; 488: 135-142, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30408481
11.
Letter to the Editor: Remission of Graves' Disease After Initiation of Ocrelizumab in Patients with Multiple Sclerosis.
Thyroid
; 33(2): 267-269, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36416241
12.
[Therapeutic plasma exchange: applications in neurology]. / Recambio plasmático terapéutico: aplicaciones en neurología.
Rev Neurol
; 60(3): 120-31, 2015 Feb 01.
Artigo
Espanhol
| MEDLINE | ID: mdl-25624088
13.
Tratamiento de la esclerosis múltiple remitente recurrente con fingolimod en la práctica clínica habitual / Treatment of relapsing-remitting multiple sclerosis with fingolimod in routine clinical practice
Rev. neurol. (Ed. impr.)
; 64(10): 445-453, 16 mayo, 2017. tab, graf
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-162609
14.
Recambio plasmático terapéutico: aplicaciones en neurología / Therapeutic plasma exchange: applications in neurology
Rev. neurol. (Ed. impr.)
; 60(3): 120-131, 1 feb., 2015. ilus, tab
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-132071